Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas | Zendy

Tanuj Dada | Zendy; Shibal Bhartiya | Zendy; Murugesan Vanathi | Zendy; Anita Panda | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas

Author(s) -

Tanuj Dada,

Shibal Bhartiya,

Murugesan Vanathi,

Anita Panda

Publication year - 2010

Publication title -

indian journal of ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 51

eISSN - 1998-3689

pISSN - 0301-4738

DOI - 10.4103/0301-4738.67068

Subject(s) - medicine , pars plana , vitrectomy , intraocular pressure , ophthalmology , glaucoma , refractory (planetary science) , glaucoma valve , triamcinolone acetonide , neovascular glaucoma , visual acuity , diabetic retinopathy , diabetes mellitus , physics , astrobiology , endocrinology

Glaucoma drainage devices are an option in refractory glaucomas for control of intraocular pressure (IOP). We evaluated the outcome of pars plana Ahmed glaucoma valve along with triamcinolone-assisted vitrectomy in 11 eyes with uncontrolled IOP on maximum tolerable antiglaucoma therapy. The mean preoperative IOP of 33.64 +/- 5.99 (range 26 to 44 mmHg) decreased to 17.09 +/- 2.26 (range 14 to 20 mmHg) and 17.45 +/- 1.81 mm of Hg (range 14 to 24 mmHg) at 6 and 12 months following surgery. The mean number of antiglaucoma medications decreased from 3.27 +/- 0.05 to 0.64 +/- 0.67 and 0.55 +/- 0.6 at 6 and 12 months following surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research